Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DNAH7 DNAH9 DYNC1H1	8.40e-06	18	149	4	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DNAH7 DNAH9 DYNC1H1	5.30e-05	28	149	4	GO:0051959
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH7 DNAH9 DYNC1H1	1.62e-04	37	149	4	GO:0045505
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 DNAH7 KIF14 DNAH9 DYNC1H1	1.77e-04	70	149	5	GO:0003777
GeneOntologyMolecularFunction	glutamate-gated receptor activity	GRIA2 GRIN2C GRIN2D	2.56e-04	17	149	3	GO:0004970
GeneOntologyMolecularFunction	ATP hydrolysis activity	ATP6V1A ABCC1 DNAH3 DNAH7 RECQL5 HELZ2 KIF14 ATP2A3 ATP2B1 DNAH9 DYNC1H1	4.85e-04	441	149	11	GO:0016887
GeneOntologyCellularComponent	postsynapse	ANK3 MAP2 MAP4 SPTAN1 RTN4 HNRNPM GRIA2 GRIN2C GRIN2D PRRT2 SLC1A2 ADD2 ITPR1 IGF1R AP2B1 ICAM5 SMCR8 ATP2B1 SLC29A1	1.28e-04	1018	150	19	GO:0098794
GeneOntologyCellularComponent	microtubule associated complex	DNAH3 MAP2 MAP4 DNAH7 KIF14 DNAH9 DYNC1H1	1.65e-04	161	150	7	GO:0005875
GeneOntologyCellularComponent	presynapse	ATP6V1A CACNA2D2 PARK7 GRIA2 GRIN2D PRRT2 PLEKHG5 SLC1A2 ITPR1 PPP3CC PTPRD AP1B1 AP2B1 SMCR8 ATP2B1 SLC29A1 EPHA3	2.15e-04	886	150	17	GO:0098793
GeneOntologyCellularComponent	glutamatergic synapse	MAP2 SPTAN1 RTN4 HNRNPM GRIA2 GRIN2C GRIN2D PRRT2 SLC1A2 ADD2 IGF1R PPP3CC PTPRD AP2B1 ICAM5 ATP2B1	2.65e-04	817	150	16	GO:0098978
GeneOntologyCellularComponent	nuclear inclusion body	RANBP2 NBN RGPD3	3.77e-04	20	150	3	GO:0042405
GeneOntologyCellularComponent	neuron to neuron synapse	ANK3 MAP2 MAP4 RTN4 HNRNPM GRIA2 GRIN2C GRIN2D PRRT2 ADD2 ITPR1 PTPRD	4.02e-04	523	150	12	GO:0098984
GeneOntologyCellularComponent	postsynaptic density	ANK3 MAP2 MAP4 RTN4 HNRNPM GRIA2 GRIN2C GRIN2D PRRT2 ADD2 ITPR1	4.23e-04	451	150	11	GO:0014069
GeneOntologyCellularComponent	dynein complex	DNAH3 DNAH7 DNAH9 DYNC1H1	6.10e-04	54	150	4	GO:0030286
GeneOntologyCellularComponent	asymmetric synapse	ANK3 MAP2 MAP4 RTN4 HNRNPM GRIA2 GRIN2C GRIN2D PRRT2 ADD2 ITPR1	6.74e-04	477	150	11	GO:0032279
GeneOntologyCellularComponent	axonemal dynein complex	DNAH3 DNAH7 DNAH9	7.42e-04	25	150	3	GO:0005858
GeneOntologyCellularComponent	calcineurin complex	ITPR1 PPP3CC	7.53e-04	6	150	2	GO:0005955
GeneOntologyCellularComponent	interphotoreceptor matrix	IMPG1 VCAN	7.53e-04	6	150	2	GO:0033165
GeneOntologyCellularComponent	presynaptic membrane	CACNA2D2 GRIA2 GRIN2D PRRT2 SLC1A2 PTPRD AP2B1 ATP2B1	8.94e-04	277	150	8	GO:0042734
GeneOntologyCellularComponent	postsynaptic specialization	ANK3 MAP2 MAP4 RTN4 HNRNPM GRIA2 GRIN2C GRIN2D PRRT2 ADD2 ITPR1	1.04e-03	503	150	11	GO:0099572
GeneOntologyCellularComponent	synaptic membrane	ANK3 CACNA2D2 RTN4 GRIA2 GRIN2C GRIN2D PRRT2 SLC1A2 ITPR1 PTPRD AP2B1 ATP2B1	1.04e-03	583	150	12	GO:0097060
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RANBP2 RGPD3	1.39e-03	8	150	2	GO:1990723
GeneOntologyCellularComponent	NMDA selective glutamate receptor complex	GRIN2C GRIN2D	1.78e-03	9	150	2	GO:0017146
GeneOntologyCellularComponent	platelet dense tubular network membrane	ITPR1 ATP2A3	1.78e-03	9	150	2	GO:0031095
GeneOntologyCellularComponent	dendritic shaft	MAP2 GRIA2 SLC1A2 FUBP3	1.99e-03	74	150	4	GO:0043198
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	DNAH3 MAP2 MAP4 GRIA2 DNAH7 SPAG17 DNAH9 DYNC1H1	2.10e-03	317	150	8	GO:0032838
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH7	2.22e-03	10	150	2	GO:0036156
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RANBP2 RGPD3	2.22e-03	10	150	2	GO:0044614
GeneOntologyCellularComponent	presynaptic active zone membrane	CACNA2D2 GRIA2 GRIN2D ATP2B1	2.41e-03	78	150	4	GO:0048787
GeneOntologyCellularComponent	perisynaptic extracellular matrix	TNC VCAN	2.70e-03	11	150	2	GO:0098966
GeneOntologyCellularComponent	platelet dense tubular network	ITPR1 ATP2A3	2.70e-03	11	150	2	GO:0031094
GeneOntologyCellularComponent	apical plasma membrane	SLC12A6 ATP6V1A ABCC1 AMN SLC2A2 PKHD1 PLD1 ATP2B1 SLC29A1 VCAM1	2.76e-03	487	150	10	GO:0016324
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH7 DNAH9 DYNC1H1	3.76e-06	14	150	4	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH7 DNAH9 DYNC1H1	3.76e-06	14	150	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH7 DNAH9 DYNC1H1	3.76e-06	14	150	4	IPR013602
Domain	DHC_N2	DNAH3 DNAH7 DNAH9 DYNC1H1	3.76e-06	14	150	4	PF08393
Domain	MT	DNAH3 DNAH7 DNAH9 DYNC1H1	3.76e-06	14	150	4	PF12777
Domain	AAA_8	DNAH3 DNAH7 DNAH9 DYNC1H1	3.76e-06	14	150	4	PF12780
Domain	DHC_fam	DNAH3 DNAH7 DNAH9 DYNC1H1	5.09e-06	15	150	4	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH7 DNAH9 DYNC1H1	5.09e-06	15	150	4	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH7 DNAH9 DYNC1H1	5.09e-06	15	150	4	IPR004273
Domain	Clathrin_b-adaptin_app_Ig-like	AP1B1 AP2B1	6.41e-05	2	150	2	IPR013037
Domain	-	AP1B1 AP2B1	6.41e-05	2	150	2	2.60.40.1150
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH9 DYNC1H1	1.73e-04	14	150	3	IPR011704
Domain	AAA_5	DNAH3 DNAH9 DYNC1H1	1.73e-04	14	150	3	PF07728
Domain	TAU_MAP_2	MAP2 MAP4	1.91e-04	3	150	2	PS51491
Domain	Tubulin-binding	MAP2 MAP4	1.91e-04	3	150	2	PF00418
Domain	AP_complex_bsu_1_2_4	AP1B1 AP2B1	1.91e-04	3	150	2	IPR016342
Domain	MAP_tubulin-bd_rpt	MAP2 MAP4	1.91e-04	3	150	2	IPR001084
Domain	TAU_MAP_1	MAP2 MAP4	1.91e-04	3	150	2	PS00229
Domain	B2-adapt-app_C	AP1B1 AP2B1	1.91e-04	3	150	2	PF09066
Domain	MAP2/MAP4/Tau	MAP2 MAP4	1.91e-04	3	150	2	IPR027324
Domain	-	IMPG1 MUC16 TMPRSS11A	2.15e-04	15	150	3	3.30.70.960
Domain	Lig_chan-Glu_bd	GRIA2 GRIN2C GRIN2D	3.79e-04	18	150	3	PF10613
Domain	Glu/Gly-bd	GRIA2 GRIN2C GRIN2D	3.79e-04	18	150	3	IPR019594
Domain	Lig_chan-Glu_bd	GRIA2 GRIN2C GRIN2D	3.79e-04	18	150	3	SM00918
Domain	Iontro_rcpt	GRIA2 GRIN2C GRIN2D	3.79e-04	18	150	3	IPR001320
Domain	Iono_rcpt_met	GRIA2 GRIN2C GRIN2D	3.79e-04	18	150	3	IPR001508
Domain	Lig_chan	GRIA2 GRIN2C GRIN2D	3.79e-04	18	150	3	PF00060
Domain	PBPe	GRIA2 GRIN2C GRIN2D	3.79e-04	18	150	3	SM00079
Domain	B2-adapt-app_C	AP1B1 AP2B1	3.80e-04	4	150	2	SM01020
Domain	B-adaptin_app_sub_C	AP1B1 AP2B1	3.80e-04	4	150	2	IPR015151
Domain	AP_beta	AP1B1 AP2B1	6.31e-04	5	150	2	IPR026739
Domain	SEA	IMPG1 MUC16 TMPRSS11A	6.99e-04	22	150	3	PF01390
Domain	SEA	IMPG1 MUC16 TMPRSS11A	7.99e-04	23	150	3	PS50024
Domain	SEA_dom	IMPG1 MUC16 TMPRSS11A	7.99e-04	23	150	3	IPR000082
Domain	ICAM_VCAM_N	ICAM5 VCAM1	9.41e-04	6	150	2	IPR003987
Domain	Beta2_adaptin/TBP_C_dom	AP1B1 AP2B1	9.41e-04	6	150	2	IPR012295
Domain	-	AP1B1 AP2B1	9.41e-04	6	150	2	3.30.310.10
Domain	AAA	ABCC1 DNAH3 DNAH7 HELZ2 DNAH9 DYNC1H1	1.09e-03	144	150	6	SM00382
Domain	AAA+_ATPase	ABCC1 DNAH3 DNAH7 HELZ2 DNAH9 DYNC1H1	1.09e-03	144	150	6	IPR003593
Domain	FHA	NBN KIF14 CEP170B	1.44e-03	28	150	3	SM00240
Domain	DHC_N1	DNAH9 DYNC1H1	1.74e-03	8	150	2	PF08385
Domain	Coatomer/calthrin_app_sub_C	AP1B1 AP2B1	1.74e-03	8	150	2	IPR009028
Domain	Dynein_heavy_dom-1	DNAH9 DYNC1H1	1.74e-03	8	150	2	IPR013594
Domain	FHA_DOMAIN	NBN KIF14 CEP170B	1.94e-03	31	150	3	PS50006
Domain	FHA	NBN KIF14 CEP170B	1.94e-03	31	150	3	PF00498
Domain	fn3	CHL1 IGFN1 TNC IGF1R PTPRD EPHA3	1.99e-03	162	150	6	PF00041
Domain	Alpha_adaptinC2	AP1B1 AP2B1	2.22e-03	9	150	2	PF02883
Domain	Clathrin_a/b/g-adaptin_app_Ig	AP1B1 AP2B1	2.22e-03	9	150	2	IPR008152
Domain	Alpha_adaptinC2	AP1B1 AP2B1	2.22e-03	9	150	2	SM00809
Domain	-	CHL1 IGFN1 TNC SEMA3G CCDC141 F13A1 IGF1R PTPRD ICAM5 VCAN PKHD1 VCAM1 EPHA3	2.70e-03	663	150	13	2.60.40.10
Domain	-	NBN KIF14 CEP170B	2.99e-03	36	150	3	2.60.200.20
Domain	FHA_dom	NBN KIF14 CEP170B	2.99e-03	36	150	3	IPR000253
Domain	ANF_lig-bd_rcpt	GRIA2 GRIN2C GRIN2D	3.23e-03	37	150	3	IPR001828
Domain	ANF_receptor	GRIA2 GRIN2C GRIN2D	3.23e-03	37	150	3	PF01094
Domain	Peripla_BP_I	GRIA2 GRIN2C GRIN2D	3.75e-03	39	150	3	IPR028082
Domain	FN3	CHL1 IGFN1 TNC IGF1R PTPRD EPHA3	3.84e-03	185	150	6	SM00060
Domain	Ran_BP1	RANBP2 RGPD3	4.01e-03	12	150	2	PF00638
Domain	RANBD1	RANBP2 RGPD3	4.01e-03	12	150	2	PS50196
Domain	Coatomer/clathrin_app_Ig-like	AP1B1 AP2B1	4.01e-03	12	150	2	IPR013041
Domain	Ig-like_fold	CHL1 IGFN1 TNC SEMA3G CCDC141 F13A1 IGF1R PTPRD ICAM5 VCAN PKHD1 VCAM1 EPHA3	4.59e-03	706	150	13	IPR013783
Domain	RanBD	RANBP2 RGPD3	4.72e-03	13	150	2	SM00160
Domain	Ran_bind_dom	RANBP2 RGPD3	4.72e-03	13	150	2	IPR000156
Domain	FN3	CHL1 IGFN1 TNC IGF1R PTPRD EPHA3	5.46e-03	199	150	6	PS50853
Domain	SEA	IMPG1 MUC16	5.47e-03	14	150	2	SM00200
Domain	Clathrin/coatomer_adapt-like_N	AP1B1 AP2B1	6.28e-03	15	150	2	IPR002553
Domain	Adaptin_N	AP1B1 AP2B1	6.28e-03	15	150	2	PF01602
Domain	Armadillo	ARMC1 AP1B1 AP2B1	6.36e-03	47	150	3	IPR000225
Domain	FN3_dom	CHL1 IGFN1 TNC IGF1R PTPRD EPHA3	6.90e-03	209	150	6	IPR003961
Domain	Guanylate_kinase_CS	MPP1 GUK1	7.14e-03	16	150	2	IPR020590
Domain	ATPase_P-typ_TM_dom	ATP2A3 ATP2B1	7.14e-03	16	150	2	IPR023298
Domain	-	ATP2A3 ATP2B1	7.14e-03	16	150	2	1.20.1110.10
Pathway	KEGG_LONG_TERM_POTENTIATION	GRIA2 GRIN2C GRIN2D CREBBP ITPR1 PPP3CC	2.56e-05	70	118	6	M3115
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RANBP2 ANK3 PARK7 SPTAN1 HNRNPM GRIA2 GRIN2D ARMCX4 SLC1A2 ITIH4 UBE2O PPP2R5D PTPRD WIZ AP1B1 AP2B1 ICAM5 RGPD3 SAFB2 RABGEF1 CEP170B DYNC1H1	2.24e-10	963	151	22	28671696
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	HNRNPDL ERCC5 ZMPSTE24 ANK3 MAP4 PPRC1 ACVR2A WDFY4 PAICS F13A1 ITPR1 MESD SEPSECS CSNK1G3 EXOC3L4 VCAN SAFB2 PLD1 ATP2B1 FUBP3 SLC29A1 VPS13B	2.00e-09	1084	151	22	11544199
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HNRNPDL ATP6V1A RANBP2 GBF1 ACACA RRP1B CACNA2D2 MAP4 PARK7 SPTAN1 RTN4 HNRNPM PAICS UBE2O PMPCA SUPT5H SAFB2 KIF14 HARS1 MED23 ATP2B1 FUBP3 DYNC1H1 GNL3 SDHA	2.74e-09	1425	151	25	30948266
Pubmed	140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.	MAP2 SPTAN1 RTN4 PAICS ADD2 ITPR1 AP1B1 AP2B1 ATP2B1 DYNC1H1	2.75e-09	163	151	10	16512683
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	HNRNPDL ATP6V1A MAP2 MAP4 PARK7 SPTAN1 RTN4 HNRNPM SLC1A2 PAICS AP1B1 AP2B1 GUK1 ATP2B1 DYNC1H1 SDHA	2.79e-09	552	151	16	36293380
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	ATP6V1A ANK3 MAP2 PARK7 SPTAN1 RTN4 SLC1A2 ADD2 ITPR1 AP1B1 AP2B1 ATP2B1 DYNC1H1 SDHA	2.95e-09	403	151	14	30562941
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RANBP2 ACACA RRP1B MAP4 SPTAN1 PAICS UBE2O AP1B1 AP2B1 SUPT5H PHF3 HELZ2 KIF14 FUBP3 DYNC1H1 GNL3 SDHA	4.31e-09	653	151	17	22586326
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ATP6V1A RANBP2 ACACA ANK3 MAP2 MAP4 PARK7 SPTAN1 RTN4 HNRNPM GRIA2 SLC1A2 ITPR1 MESD UBE2O PPP2R5D RGPD3 PITPNM3 RABGEF1 CRYBG3 CEP170B SDHA	4.93e-09	1139	151	22	36417873
Pubmed	Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration.	HNRNPDL GBF1 PRRT2 PPP3CC AP1B1 AP2B1 VCAN SDHA	1.09e-08	97	151	8	22360420
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	HNRNPDL SLC12A6 RANBP2 ERCC5 ZMPSTE24 PPRC1 PCDHGA1 SPTAN1 HNRNPM GRIA2 ASIC5 ZFC3H1 PRX MTAP PMPCA AP2B1 RGPD3 PKHD1 SAFB2 SPAG17 ATP2A3 ATP2B1 FUBP3 ZNF292	1.62e-08	1442	151	24	35575683
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ZNF131 ANK3 RRP1B MAP2 PARK7 SPTAN1 RTN4 HNRNPM NBN ZFC3H1 TRAPPC8 ARMC1 ADD2 ITPR1 UBE2O PPP2R5D COCH PMPCA CRYBG3 SMCR8 ATP2B1 GNL3 VPS13B SDHA	2.90e-08	1487	151	24	33957083
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	RANBP2 NBN ZFC3H1 CREBBP WIZ AP1B1 BRCA2 AP2B1 SUPT5H RECQL5	5.24e-08	222	151	10	37071664
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SLC12A6 ATP6V1A ANK3 MAP2 MAP4 TNC PARK7 SPTAN1 RTN4 HNRNPM GRIA2 PLEKHG5 SLC1A2 ADD2 UBE2O AP1B1 AP2B1 ICAM5 VCAN ATP2B1 CEP170B DYNC1H1 SDHA	6.30e-08	1431	151	23	37142655
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	ATP6V1A MAP4 TKFC AP2B1 HELZ2 ATP2A3 FUBP3 CNOT4 DYNC1H1 SDHA AHNAK2	8.44e-08	298	151	11	30737378
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MPP1 HNRNPDL RANBP2 GBF1 ACACA MAP4 SPTAN1 RTN4 NBN ZFC3H1 WIZ PHF3 ECI2 FUBP3 AHNAK2 ZNF292	1.20e-07	724	151	16	36232890
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ACACA ANK3 MAP4 SPTAN1 NBN CREBBP PAICS UBE2O WIZ PHF3 ICAM5 KIF14 MED23 DYNC1H1	1.38e-07	549	151	14	38280479
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ABCC1 RANBP2 ANK3 RRP1B SPTAN1 NBN ADD2 ITPR1 PPP2R5D PPP3CC PTPRD WIZ PMPCA SUPT5H KIF14 CRYBG3 HARS1 ATP2B1 SLC29A1	1.63e-07	1049	151	19	27880917
Pubmed	Defining the membrane proteome of NK cells.	MPP1 ABCC1 RANBP2 GBF1 ZMPSTE24 HNRNPM LRRC8D PAICS ITPR1 MGAT2 AP2B1 HELZ2 KIF14 ECI2 PLD1 ATP2B1 FUBP3 SLC29A1 DYNC1H1 GNL3	1.84e-07	1168	151	20	19946888
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	HNRNPDL ATP6V1A ABCC1 ACACA PPRC1 SPTAN1 CREBBP ITIH4 ITPR1 WIZ BRCA2 SAFB2 KIF14 MED23 DYNC1H1 SDHA	2.07e-07	754	151	16	35906200
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HNRNPDL ATP6V1A RANBP2 ERCC5 ACACA RRP1B MAP4 PARK7 SPTAN1 HNRNPM LRRC8D PAICS UBE2O PPP2R5D MTAP AP1B1 AP2B1 ECI2 DYNC1H1 GNL3 SDHA AHNAK2	2.22e-07	1415	151	22	28515276
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ATP6V1A ZMPSTE24 ACACA ANK3 PARK7 SPTAN1 RTN4 HNRNPM PAICS MTAP AP1B1 AP2B1 HARS1 SPAG17 DYNC1H1 AHNAK2	5.09e-07	807	151	16	30575818
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	ATP6V1A RANBP2 ACACA PARK7 HNRNPM WIZ BRCA2 SUPT5H RGPD3 MED23 DYNC1H1	5.11e-07	357	151	11	37059091
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	RANBP2 ZMPSTE24 ANK3 MAP4 RTN4 HNRNPM PAICS ADD2 PPP2R5D CRYBG3 SMCR8 ATP2B1 DYNC1H1 SDHA EPHA3	5.17e-07	708	151	15	39231216
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	GBF1 ANK3 RRP1B MAP4 ZFC3H1 COCH PHF3 ASXL3 KIF14 DNAH9 TMPRSS11A	5.70e-07	361	151	11	26167880
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	SLC12A6 ATP6V1A MAP2 SPTAN1 SLC1A2 ADD2 ITPR1 IGF1R AP1B1 BRCA2 AP2B1 ICAM5 ATP2A3 DYNC1H1	6.07e-07	621	151	14	22794259
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	RANBP2 ACACA MAP4 RTN4 HNRNPM NBN CREBBP BRCA2 PHF3 RGPD3 MED23 AHNAK2	6.12e-07	444	151	12	34795231
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	HNRNPDL ATP6V1A RANBP2 GBF1 ACACA ANK3 MAP4 PARK7 SPTAN1 HNRNPM PAICS ADD2 UBE2O MTAP AP1B1 AP2B1 HARS1 DYNC1H1 GNL3	6.45e-07	1149	151	19	35446349
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ANK3 PPRC1 SPTAN1 ZFC3H1 ARMCX4 CREBBP PAICS UBE2O POLR3B PTPRD WIZ AP2B1 GUK1 SUPT5H WIF1 ANKRD24 HARS1 DYNC1H1 SDHA ZNF292	8.19e-07	1285	151	20	35914814
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	HNRNPDL ATP6V1A RANBP2 GBF1 ACACA SPTAN1 HNRNPM PAICS UBE2O AP1B1 AP2B1 FUBP3 DYNC1H1 GNL3	8.35e-07	638	151	14	33239621
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	RANBP2 MAP2 TNC SPTAN1 GRIN2D ADD2 RGPD3 SAFB2 CEP170B	8.39e-07	231	151	9	16452087
Pubmed	Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.	CHL1 ERCC5 MUC16 NBN ACVR2A F13A1 IGF1R BRCA2	8.47e-07	170	151	8	19064572
Pubmed	Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.	ATP6V1A MAP2 MAP4 SPTAN1 SLC1A2 AP1B1 AP2B1 ICAM5	1.10e-06	176	151	8	18614564
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	ATP6V1A GBF1 ACACA MAP2 MAP4 SPTAN1 HNRNPM PAICS UBE2O TKFC PPP2R5D MTAP AP1B1 AP2B1 SUPT5H RABGEF1 HARS1 GMPPB FUBP3 DYNC1H1 AHNAK2	1.42e-06	1455	151	21	22863883
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	SLC12A6 ATP6V1A ABCC1 RANBP2 ACACA SPTAN1 HNRNPM PAICS FUBP3 SLC29A1 DYNC1H1 GNL3	1.51e-06	484	151	12	31995728
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	ATP6V1A ABCC1 ZMPSTE24 PARK7 HNRNPM PAICS TKFC AP1B1 PMPCA AP2B1 HARS1 ATP2B1 SLC29A1 DYNC1H1 SDHA ZNF292	1.53e-06	878	151	16	37223481
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	ANK3 PARK7 SPTAN1 GRIA2 GRIN2D SLC1A2 ITIH4 UBE2O DYNC1H1	1.67e-06	251	151	9	27507650
Pubmed	Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.	ERCC5 GBF1 NBN TNFRSF10D TNFRSF17 PLEKHG5 BRCA2 ICAM5 VCAM1	2.44e-06	263	151	9	19773279
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	SLC12A6 ABCC1 ACACA ANK3 ADD2 IGF1R CSNK1G3 ATP2B1 SLC29A1 SDHA EPHA3	2.53e-06	421	151	11	36976175
Pubmed	Early onset of NMDA receptor GluR epsilon 1 (NR2A) expression and its abundant postsynaptic localization in developing motoneurons of the mouse hypoglossal nucleus.	MAP2 GRIN2C GRIN2D	2.77e-06	7	151	3	12103442
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	HNRNPDL ABCC1 RANBP2 GBF1 MAP4 SPTAN1 HNRNPM UBE2O TKFC ECI2 FUBP3 DYNC1H1 GNL3 SDHA	2.95e-06	711	151	14	33022573
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ATP6V1A MAP2 MAP4 TNC SPTAN1 RTN4 SLC1A2 ADD2 PITPNM3 CEP170B	3.10e-06	347	151	10	17114649
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZNF131 ATP6V1A RANBP2 ACACA MAP4 PARK7 RTN4 HNRNPM NBN UBE2O WIZ AP2B1 SAFB2 SMCR8 GNL3 AHNAK2	3.37e-06	934	151	16	33916271
Pubmed	Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling.	MAP2 SPTAN1 ITPR1 PPP3CC AP2B1 ATP2B1 DYNC1H1	3.87e-06	147	151	7	16959763
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	RANBP2 ACACA PARK7 HNRNPM NBN PAICS AP1B1 PMPCA AP2B1 ATP2B1 FUBP3 DYNC1H1	4.12e-06	534	151	12	35032548
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	ANK3 SPTAN1 GRIA2 GRIN2D AP1B1 AP2B1 PHF3 CEP170B DYNC1H1	4.19e-06	281	151	9	28706196
Pubmed	BioID-based proteomic analysis of the Bid interactome identifies novel proteins involved in cell-cycle-dependent apoptotic priming.	HNRNPDL MAP4 PAICS DYNC1H1 AHNAK2	4.22e-06	55	151	5	33067418
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TNC MUC16 NBN DNAH7 CREBBP DSN1 TBC1D32 AP1B1 ASXL3 PITPNM3 SMCR8 ATP2B1 AHNAK2	4.68e-06	638	151	13	31182584
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RANBP2 MAP4 PARK7 PAICS WIZ AP1B1 AP2B1 PHF3 RGPD3 DYNC1H1	5.46e-06	370	151	10	22922362
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GBF1 ACACA MAP2 MAP4 SPTAN1 DNAH7 IGF1R PHF3 KIF14 RABGEF1 CRYBG3 ATP2B1 CNOT4 CEP170B AHNAK2	5.67e-06	861	151	15	36931259
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ATP6V1A MAP4 RTN4 NBN POLR3B PPP2R5D AP1B1 AP2B1 SUPT5H MED23 DYNC1H1 SDHA	6.67e-06	560	151	12	35241646
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HNRNPDL RANBP2 ACACA MAP4 PARK7 SPTAN1 HNRNPM CREBBP PAICS POLR3B AP2B1 RECQL5 SAFB2 GMPPB ATP2B1 FUBP3 DYNC1H1 GNL3 AHNAK2	6.94e-06	1353	151	19	29467282
Pubmed	Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer.	HNRNPDL RANBP2 ACACA RRP1B GNL3	8.28e-06	63	151	5	34718347
Pubmed	Caspr2 interacts with type 1 inositol 1,4,5-trisphosphate receptor in the developing cerebellum and regulates Purkinje cell morphology.	MAP2 MAP4 ITPR1	9.41e-06	10	151	3	32675284
Pubmed	DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization.	HNRNPDL RANBP2 MAP4 HNRNPM PAICS DYNC1H1 SDHA	1.21e-05	175	151	7	25756610
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RANBP2 RTN4 RGPD3	1.29e-05	11	151	3	35771867
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	MAP2 MAP4 RTN4 HNRNPM TRAPPC8 ADD2 PHF3 SAFB2	1.30e-05	246	151	8	15345747
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	RANBP2 MAP4 SPTAN1 HNRNPM SUPT5H PHF3 SAFB2 DYNC1H1 AHNAK2	1.59e-05	332	151	9	32786267
Pubmed	Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex.	MAP2 GRIA2 GRIN2C SLC1A2	1.61e-05	35	151	4	35858542
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	RANBP2 ZMPSTE24 MAP4 RTN4 PAICS SUPT5H ATP2B1 DYNC1H1 SDHA AHNAK2	1.71e-05	422	151	10	27342126
Pubmed	An integrated genetic, radiation hybrid, physical and transcription map of a region of distal mouse chromosome 12, including an imprinted locus and the 'Legs at odd angles' (Loa) mutation.	AMN CEP170B DYNC1H1	1.72e-05	12	151	3	11867214
Pubmed	Adhesion molecules close homolog of L1 and tenascin-C affect blood-spinal cord barrier repair.	CHL1 TNC	1.87e-05	2	151	2	22473292
Pubmed	Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.	TNC VCAN	1.87e-05	2	151	2	16493581
Pubmed	Occurrence of PG-Lb, a leucine-rich small chondroitin/dermatan sulphate proteoglycan in mammalian epiphyseal cartilage: molecular cloning and sequence analysis of the mouse cDNA.	EPYC VCAN	1.87e-05	2	151	2	8836137
Pubmed	NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.	RTN4 NUS1	1.87e-05	2	151	2	17764014
Pubmed	Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.	GRIN2C GRIN2D	1.87e-05	2	151	2	29317596
Pubmed	NMDA GluN2C/2D receptors contribute to synaptic regulation and plasticity in the anterior cingulate cortex of adult mice.	GRIN2C GRIN2D	1.87e-05	2	151	2	33766086
Pubmed	Expression of Nogo isoforms and Nogo-B receptor (NgBR) in non-small cell lung carcinomas.	RTN4 NUS1	1.87e-05	2	151	2	25075030
Pubmed	Expression of receptor protein tyrosine phosphatase δ, PTPδ, in mouse central nervous system.	MAP2 PTPRD	1.87e-05	2	151	2	27026654
Pubmed	In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.	GRIN2C GRIN2D	1.87e-05	2	151	2	29651654
Pubmed	Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells.	RTN4 NUS1	1.87e-05	2	151	2	16835300
Pubmed	Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes.	GRIN2C GRIN2D	1.87e-05	2	151	2	31110197
Pubmed	Enhanced function of NR2C/2D-containing NMDA receptor in the nucleus accumbens contributes to peripheral nerve injury-induced neuropathic pain and depression in mice.	GRIN2C GRIN2D	1.87e-05	2	151	2	35057644
Pubmed	The armadillo family of structural proteins.	ARMCX4 ARMC1	1.87e-05	2	151	2	9770300
Pubmed	Interphase and monoastral-mitotic phenotypes of overexpressed MAP4 are modulated by free tubulin concentrations.	MAP2 MAP4	1.87e-05	2	151	2	12890753
Pubmed	GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance.	ABCC1 IGF1R	1.87e-05	2	151	2	28266043
Pubmed	NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.	GRIN2C GRIN2D	1.87e-05	2	151	2	31786200
Pubmed	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.	TNC VCAN	1.87e-05	2	151	2	15073129
Pubmed	Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis.	NBN BRCA2	1.87e-05	2	151	2	34674288
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	HNRNPDL ZNF131 RANBP2 RRP1B MAP4 HNRNPM NBN ZNF711 WIZ BRCA2 PHF3 RECQL5 SAFB2 FUBP3 GNL3	1.89e-05	954	151	15	36373674
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	HNRNPDL MAP4 SPTAN1 RTN4 HNRNPM NBN AP1B1 AP2B1 FUBP3	1.92e-05	340	151	9	24332808
Pubmed	Phosphorylation of BACH1 switches its function from transcription factor to mitotic chromosome regulator and promotes its interaction with HMMR.	ZNF131 MAP4 SUPT5H FUBP3 DYNC1H1	1.95e-05	75	151	5	29459360
Pubmed	A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.	ERCC5 NBN IGF1R BRCA2 ICAM5	1.95e-05	75	151	5	20644561
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	RANBP2 GBF1 ZMPSTE24 RRP1B RTN4 HNRNPM ZFC3H1 ZNF711 MGAT2 IGF1R PPP2R5D PHF3 NUS1 SAFB2 MED23 ATP2B1 SLC29A1	2.02e-05	1203	151	17	29180619
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	RANBP2 ANK3 PARK7 HNRNPM MUC16 PAICS MTAP AP2B1 RGPD3 KIF14 HARS1 FUBP3 CNOT4 DYNC1H1	2.03e-05	844	151	14	25963833
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RANBP2 ANK3 HNRNPM UBE2O CRYBG3 FUBP3 VPS13B AHNAK2	2.10e-05	263	151	8	34702444
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	MAP4 SPTAN1 PAICS IGF1R AP2B1 DYNC1H1 SDHA	2.14e-05	191	151	7	33762435
Pubmed	PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum.	MAP2 GRIN2C PRRT2	2.22e-05	13	151	3	29056747
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RANBP2 ANK3 RGPD3	2.22e-05	13	151	3	31427429
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	RANBP2 GBF1 RRP1B RTN4 PAICS SEPSECS UBE2O PTPRD AP1B1 PMPCA AP2B1 SUPT5H ATP2B1 FUBP3 SDHA	2.40e-05	974	151	15	28675297
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	ZMPSTE24 SPTAN1 HNRNPM AP2B1 ATP2B1 DYNC1H1 GNL3 AHNAK2	2.41e-05	268	151	8	33024031
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	ATP6V1A ABCC1 RANBP2 ZMPSTE24 PARK7 SPTAN1 RTN4 PLEKHG5 PAICS PTPRD PMPCA GUK1 ATP2B1 SDHA	2.46e-05	859	151	14	31536960
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH7 DYNC1H1	2.82e-05	14	151	3	9373155
Pubmed	From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development.	MAP2 GRIA2 SLC1A2	2.82e-05	14	151	3	16880397
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	RRP1B MEX3D RTN4 AP2B1 PLD1 ATP2B1 CNOT4 DYNC1H1 EPHA3	2.87e-05	358	151	9	32460013
Pubmed	An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies.	MPP1 MAP4 GRIN2C ACVR2A ATP2B1	3.38e-05	84	151	5	15123239
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	RANBP2 GBF1 MAP4 SPTAN1 RTN4 TRAPPC8 PAICS ITPR1 RGPD3 VPS13B AHNAK2	4.11e-05	568	151	11	37774976
Pubmed	Trps1 activates a network of secreted Wnt inhibitors and transcription factors crucial to vibrissa follicle morphogenesis.	EPYC TNC WIF1	4.31e-05	16	151	3	22115758
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	ATP6V1A RANBP2 ACACA SPTAN1 HNRNPM PAICS UBE2O FUBP3 DYNC1H1 SDHA	4.80e-05	477	151	10	31300519
Pubmed	Chemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure.	GRIN2C GRIN2D PPP3CC	5.22e-05	17	151	3	24086760
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	HNRNPDL RRP1B MAP4 MEX3D HNRNPM UBE2O SUPT5H HELZ2 SAFB2 FUBP3 CNOT4 DYNC1H1 GNL3	5.45e-05	807	151	13	22681889
Interaction	AP2S1 interactions	RANBP2 ACACA MAP2 MAP4 PAICS AP1B1 AP2B1 KIF14 VCAM1	4.49e-07	130	146	9	int:AP2S1
Interaction	SLX4 interactions	ATP6V1A RANBP2 ACACA PARK7 HNRNPM NBN ZFC3H1 CREBBP WIZ AP1B1 BRCA2 AP2B1 SUPT5H RECQL5 RGPD3 MED23 DYNC1H1	8.90e-07	572	146	17	int:SLX4
Interaction	GJD3 interactions	ABCC1 GBF1 ZMPSTE24 SPTAN1 RTN4 TRAPPC8 LRRC8D ITPR1 AP1B1 NUS1 PLD1 SMCR8 ATP2B1 SLC29A1 VPS13B	1.11e-06	454	146	15	int:GJD3
Interaction	RAB11A interactions	ABCC1 GBF1 RRP1B SPTAN1 RTN4 GRIA2 TRAPPC8 TKFC IGF1R AP1B1 CSNK1G3 PRG2 RABGEF1 PLD1 CRYBG3 SMCR8 ATP2B1 SLC29A1 VPS13B AHNAK2	2.38e-06	830	146	20	int:RAB11A
Interaction	CAV1 interactions	SLC12A6 ABCC1 GBF1 ANK3 SPTAN1 ADD2 UBE2O IGF1R MTAP CSNK1G3 KIF14 RABGEF1 PLD1 SMCR8 ATP2B1 SLC29A1 VPS13B AHNAK2	5.19e-06	724	146	18	int:CAV1
Interaction	BAP1 interactions	HNRNPDL ZNF131 ATP6V1A RANBP2 GBF1 ACACA ANK3 MAP4 PARK7 SPTAN1 HNRNPM NBN CREBBP PAICS ADD2 UBE2O IGF1R MTAP AP1B1 BRCA2 AP2B1 ASXL3 HARS1 DYNC1H1 GNL3	8.12e-06	1314	146	25	int:BAP1
Interaction	PPP1R9B interactions	ATP6V1A ANK3 MAP2 PARK7 SPTAN1 RTN4 SLC1A2 ADD2 ITPR1 AP1B1 AP2B1 KIF14 MED23 ATP2B1 DYNC1H1 SDHA	1.28e-05	626	146	16	int:PPP1R9B
Interaction	ISG15 interactions	ZMPSTE24 MAP4 PARK7 SPTAN1 HNRNPM IFNA2 TKFC AP2B1 HELZ2 ATP2B1 FUBP3 DYNC1H1 GNL3 AHNAK2	1.48e-05	494	146	14	int:ISG15
Interaction	PLEC interactions	DNAH3 GBF1 ANK3 MAP2 SPTAN1 HNRNPM WDFY4 PAICS IFNA2 ITPR1 BRCA2 KIF14 VCAM1	1.54e-05	430	146	13	int:PLEC
Interaction	HTT interactions	MPP1 SLC12A6 ATP6V1A IMPG1 MAP2 SPTAN1 HNRNPM ZFC3H1 SLC1A2 CREBBP DSN1 ADD2 ITPR1 IGF1R AP1B1 BRCA2 AP2B1 ICAM5 ATP2A3 DYNC1H1	1.73e-05	949	146	20	int:HTT
Interaction	KCNA3 interactions	CHL1 RANBP2 ZMPSTE24 ANK3 MAP4 RTN4 HNRNPM PRRT2 PAICS ADD2 PPP2R5D PHF3 PKHD1 CRYBG3 SMCR8 ATP2B1 DYNC1H1 SDHA EPHA3	1.78e-05	871	146	19	int:KCNA3
Interaction	LYN interactions	MPP1 SLC12A6 ABCC1 ANK3 SPTAN1 CREBBP ADD2 ITPR1 IGF1R CSNK1G3 KIF14 PLD1 ATP2B1 FUBP3 SLC29A1 EPHA3 AHNAK2	1.88e-05	720	146	17	int:LYN
Interaction	STX6 interactions	SLC12A6 GBF1 ANK3 SPTAN1 PRRT2 TRAPPC8 AP1B1 CRYBG3 SMCR8 ATP2B1 SLC29A1 VPS13B AHNAK2	2.37e-05	448	146	13	int:STX6
Interaction	USP48 interactions	HNRNPDL ATP6V1A MAP2 MAP4 PARK7 SPTAN1 RTN4 HNRNPM SLC1A2 AP1B1 AP2B1 GUK1 PRG2 ATP2B1 DYNC1H1 SDHA	2.83e-05	668	146	16	int:USP48
Interaction	SIRT7 interactions	RANBP2 ACACA RRP1B MAP4 SPTAN1 PAICS UBE2O AP1B1 AP2B1 SUPT5H PHF3 HELZ2 KIF14 FUBP3 DYNC1H1 GNL3 SDHA	2.85e-05	744	146	17	int:SIRT7
Interaction	RHOG interactions	SLC12A6 ABCC1 ACACA ANK3 PARK7 SPTAN1 RTN4 ADD2 ITPR1 PMPCA CSNK1G3 KIF14 PLD1 SMCR8 ATP2B1 SLC29A1 VPS13B SDHA AHNAK2	3.24e-05	910	146	19	int:RHOG
Interaction	YAP1 interactions	GBF1 ACACA ANK3 RRP1B MAP2 MAP4 SPTAN1 RTN4 HNRNPM CREBBP PAICS UBE2O IGF1R PHF3 ICAM5 RECQL5 WIF1 KIF14 MED23 CNOT4 DYNC1H1	4.20e-05	1095	146	21	int:YAP1
Interaction	PSMC5 interactions	ABCC1 GBF1 ACACA MAP2 MAP4 CREBBP UBE2O IGF1R KIF14 HARS1 DYNC1H1 VCAM1 SDHA	5.25e-05	484	146	13	int:PSMC5
Interaction	RAB5A interactions	SLC12A6 GBF1 MAP4 SPTAN1 RTN4 HNRNPM PRRT2 WIF1 KIF14 RABGEF1 SMCR8 ATP2B1 SLC29A1 DYNC1H1 GNL3 VPS13B	5.48e-05	706	146	16	int:RAB5A
Interaction	C17orf78 interactions	GBF1 ATP2A3 ATP2B1	7.81e-05	12	146	3	int:C17orf78
Interaction	CRY2 interactions	HNRNPDL RANBP2 MAP4 HNRNPM PAICS PPP2R5D DYNC1H1 SDHA	8.66e-05	194	146	8	int:CRY2
Interaction	BMI1 interactions	RANBP2 ACACA PARK7 NBN TRAPPC8 CREBBP IGF1R AP2B1 PHF3 HELZ2 SAFB2 ATP2A3 FUBP3 CEP170B DYNC1H1	9.02e-05	659	146	15	int:BMI1
Interaction	ZFPL1 interactions	ABCC1 GBF1 ANK3 SPTAN1 ADD2 PITPNM3 SMCR8 ATP2A3 ATP2B1 SLC29A1 VPS13B AHNAK2	1.05e-04	448	146	12	int:ZFPL1
Interaction	FUS interactions	HNRNPDL ACACA HNRNPM GRIN2D CREBBP PAICS ARMC1 MTAP SUPT5H PHF3 SAFB2 KIF14 FUBP3 DYNC1H1 GNL3 VCAM1	1.23e-04	757	146	16	int:FUS
Interaction	RAB4A interactions	SLC12A6 PARK7 SPTAN1 RTN4 TRAPPC8 AP1B1 AP2B1 RABGEF1 SMCR8 ATP2B1 VPS13B AHNAK2	1.27e-04	457	146	12	int:RAB4A
Interaction	YWHAB interactions	GBF1 MAP2 PARK7 SPTAN1 TRAPPC8 PLEKHG5 PAICS TKFC IGF1R PPP2R5D PHF3 KIF14 RABGEF1 CNOT4 CEP170B DYNC1H1 VCAM1 SDHA AHNAK2	1.36e-04	1014	146	19	int:YWHAB
Interaction	SSRP1 interactions	HNRNPDL RANBP2 HNRNPM ZFC3H1 TRAPPC8 UBE2O BRCA2 SUPT5H PHF3 SAFB2 KIF14 ATP2B1 GNL3 VCAM1 SDHA	1.38e-04	685	146	15	int:SSRP1
Interaction	MAGEA9 interactions	ZFC3H1 ITPR1 POLR3B BRCA2 HELZ2 KIF14 PLD1 SMCR8	1.40e-04	208	146	8	int:MAGEA9
Interaction	PRDX2 interactions	MPP1 ATP6V1A PARK7 GRIA2 PAICS UBE2O PPP2R5D PMPCA ASXL3 VCAM1	1.46e-04	329	146	10	int:PRDX2
Interaction	AGAP2 interactions	ANK3 SPTAN1 GRIA2 AP1B1 AP2B1 PHF3 CEP170B DYNC1H1	1.50e-04	210	146	8	int:AGAP2
Interaction	MTPN interactions	ZNF131 ATP6V1A ADD2 MTAP PMPCA GUK1 KIF14	1.55e-04	158	146	7	int:MTPN
Interaction	LGALS1 interactions	CHL1 SLC12A6 ZNF131 MUC16 IGF1R PTPRD ICAM5 VCAN KIF14 VCAM1	1.57e-04	332	146	10	int:LGALS1
Interaction	SDHAF4 interactions	ACACA PMPCA SDHA	1.59e-04	15	146	3	int:SDHAF4
Interaction	VDAC1 interactions	HNRNPDL ATP6V1A ABCC1 ZMPSTE24 ACACA PARK7 SPTAN1 RTN4 PRRT2 SAFB2 KIF14 ATP2B1 VCAM1	1.63e-04	542	146	13	int:VDAC1
Interaction	ELOF1 interactions	ACACA IGF1R SUPT5H FUBP3 CNOT4	1.65e-04	71	146	5	int:ELOF1
Interaction	KCTD13 interactions	SLC12A6 ATP6V1A ANK3 MAP2 MAP4 TNC PARK7 SPTAN1 RTN4 HNRNPM GRIA2 PLEKHG5 SLC1A2 ADD2 UBE2O AP1B1 AP2B1 ICAM5 VCAN ATP2B1 CEP170B DYNC1H1 SDHA	1.72e-04	1394	146	23	int:KCTD13
Interaction	HDAC2 interactions	MPP1 ATP6V1A MAP4 PARK7 CREBBP TKFC WIZ BRCA2 AP2B1 HELZ2 KIF14 ATP2A3 FUBP3 CNOT4 DYNC1H1 SDHA AHNAK2	1.80e-04	865	146	17	int:HDAC2
Interaction	NUP43 interactions	ZNF131 RANBP2 ERCC5 ACACA RRP1B MAP4 ZFC3H1 ZNF711 BRCA2 RECQL5 DNAH9 GNL3 AHNAK2 ZNF292	1.84e-04	625	146	14	int:NUP43
Interaction	BCL2 interactions	ACACA MEX3D RTN4 ITPR1 PPP3CC BRCA2 ATP2A3	1.88e-04	163	146	7	int:BCL2
Interaction	ARF1 interactions	GBF1 PARK7 PRRT2 PAICS IGF1R AP1B1 RABGEF1 PLD1 VCAM1	2.20e-04	282	146	9	int:ARF1
Interaction	RNF11 interactions	RTN4 ACVR2A UBE2O AP2B1 CSNK1G3 RABGEF1 ATP2B1	2.35e-04	169	146	7	int:RNF11
Interaction	DAZAP1 interactions	PAICS IGF1R MTAP KIF14 RABGEF1 FUBP3 VCAM1	2.35e-04	169	146	7	int:DAZAP1
Interaction	DNAH9 interactions	BRCA2 KIF14 DNAH9	2.35e-04	17	146	3	int:DNAH9
Interaction	EMC1 interactions	RANBP2 ZMPSTE24 RTN4 GRIA2 PAICS SUPT5H MED23 ATP2B1 DYNC1H1 SDHA AHNAK2	2.40e-04	418	146	11	int:EMC1
Interaction	POLR1E interactions	RANBP2 RRP1B ZFC3H1 CREBBP ZNF711 POLR3B WIZ BRCA2 WIF1 ZNF292	2.41e-04	350	146	10	int:POLR1E
Interaction	DNASE1L1 interactions	THSD4 CACNA2D2 MESD IGF1R ICAM5 KIF14	2.42e-04	120	146	6	int:DNASE1L1
Interaction	LAMTOR1 interactions	SLC12A6 ATP6V1A ABCC1 TRAPPC8 IGF1R PTPRD AP1B1 AP2B1 CSNK1G3 PLD1 CRYBG3 SMCR8 ATP2B1 SLC29A1 VPS13B	2.44e-04	722	146	15	int:LAMTOR1
Interaction	NR3C1 interactions	HNRNPDL ABCC1 ZMPSTE24 TNC RTN4 MUC16 NBN DNAH7 CREBBP DSN1 TBC1D32 AP1B1 ASXL3 NR0B1 PITPNM3 SMCR8 ATP2B1 AHNAK2	2.45e-04	974	146	18	int:NR3C1
Interaction	SERBP1 interactions	ATP6V1A ABCC1 ZMPSTE24 MAP4 PARK7 SPTAN1 HNRNPM PAICS UBE2O TKFC PPP2R5D AP1B1 PMPCA AP2B1 KIF14 ECI2 HARS1 ATP2B1 FUBP3 SLC29A1 DYNC1H1 SDHA ZNF292	2.55e-04	1432	146	23	int:SERBP1
Interaction	DDX17 interactions	HNRNPDL RANBP2 HNRNPM CREBBP UBE2O PTPRD SUPT5H KIF14 GNL3 VCAM1 AHNAK2	2.82e-04	426	146	11	int:DDX17
Interaction	EFTUD2 interactions	HNRNPDL RANBP2 ERCC5 ACACA RRP1B MAP4 PARK7 SPTAN1 HNRNPM LRRC8D PAICS UBE2O PPP2R5D AP1B1 AP2B1 SUPT5H KIF14 ECI2 HARS1 DYNC1H1 GNL3 VCAM1 AHNAK2	3.01e-04	1449	146	23	int:EFTUD2
Interaction	DHODH interactions	ACACA HNRNPM GMPPB GNL3 SDHA	3.07e-04	81	146	5	int:DHODH
Interaction	GRB7 interactions	HNRNPDL RANBP2 ACACA RRP1B HNRNPM GNL3 SDHA	3.22e-04	178	146	7	int:GRB7
Cytoband	16p13.1	ABCC1 TNFRSF17	6.42e-05	4	151	2	16p13.1
Cytoband	3p21.1	SEMA3G ITIH4 GNL3	3.64e-04	42	151	3	3p21.1
Cytoband	15q13	SLC12A6 MESD	3.81e-04	9	151	2	15q13
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	CACNA2D2 MAP4 SEMA3G ITIH4 GMPPB GNL3	6.55e-04	316	151	6	chr3p21
Cytoband	3p26.1	CHL1 ITPR1	6.94e-04	12	151	2	3p26.1
GeneFamily	Dyneins, axonemal	DNAH3 DNAH7 DNAH9	1.40e-04	17	110	3	536
GeneFamily	Fibronectin type III domain containing	CHL1 IGFN1 TNC IGF1R PTPRD EPHA3	4.39e-04	160	110	6	555
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN2C GRIN2D	7.55e-04	7	110	2	1201
GeneFamily	ATPases Ca2+ transporting	ATP2A3 ATP2B1	1.28e-03	9	110	2	1209
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HNRNPDL ABCC1 RANBP2 GBF1 NBN TRAPPC8 CREBBP ITPR1 IGF1R MTAP BRCA2 PHF3 KIF14 CRYBG3 ATP2B1 CNOT4 VPS13B ZNF292	2.10e-06	856	150	18	M4500
Coexpression	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	C6orf62 SPTAN1 SLA ITPR1 MGAT2 SAFB2 VCAM1 ZNF292	8.59e-06	177	150	8	M6564
Coexpression	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	ZNF131 ANK3 RRP1B ITIH4 PTPRD PLD1 MED23	9.26e-06	128	150	7	M4925
Coexpression	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	ZNF131 ANK3 RRP1B ITIH4 PTPRD PLD1 MED23	1.25e-05	134	150	7	MM748
Coexpression	GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN	AMN ASIC5 TNFRSF17 DSN1 ADD2 KIF14 GMPPB SDHA	1.28e-05	187	150	8	M4905
Coexpression	GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN	HNRNPDL C6orf62 AMN NBN TRAPPC8 MESD SEPSECS MTAP	2.08e-05	200	150	8	M7356
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP	MUC16 GRIN2D WDFY4 MED23 DNAH9 DYNC1H1 EPHA3 AHNAK2	2.08e-05	200	150	8	M7437
Coexpression	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	HNRNPDL ATP6V1A ZMPSTE24 ANK3 PARK7 NBN TRAPPC8 CREBBP IGF1R PTPRD PHF3 VCAN VCAM1	2.48e-05	568	150	13	M4023
Coexpression	KYNG_DNA_DAMAGE_UP	CHL1 ABCC1 ERCC5 MGAT2 PHF3 PRG2 KIF14 VCAM1	2.49e-05	205	150	8	M3961
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	HNRNPDL ERCC5 MAP4 ZFC3H1 ADD2 ITPR1 PMPCA VCAN SLC29A1	3.18e-05	276	150	9	M3063
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	SLC12A6 ZNF131 RANBP2 SPTAN1 RTN4 ZFC3H1 SEPSECS IGF1R PHF3 CSNK1G3 MED23 ATP2B1 FUBP3 ZNF292	3.83e-05	680	150	14	M41089
Coexpression	ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION	CHL1 GRIA2 SLA PTPRD EPHA3	4.17e-05	67	150	5	M39080
Coexpression	NABA_PROTEOGLYCANS	IMPG1 EPYC PRG2 VCAN	4.70e-05	35	150	4	M5882
Coexpression	NABA_PROTEOGLYCANS	IMPG1 EPYC PRG2 VCAN	5.26e-05	36	150	4	MM17061
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	RRP1B PPRC1 ZFC3H1 CREBBP PHF3 KIF14 ATP2B1 CNOT4 VPS13B	6.06e-05	300	150	9	M8702
Coexpression	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	THSD4 RRP1B MAP4 GRIA2 PAICS ZNF711 TKFC IGF1R HELZ2 ECI2 SLC29A1 AHNAK2	6.12e-05	534	150	12	M12522
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CHL1 IGFN1 ANK3 MAP2 RTN4 GRIA2 ACVR2A PRRT2 CCDC141 SLC1A2 TBC1D32 ASXL3 TLL1 VCAN SPAG17 ATP2B1 EPHA3 AHNAK2	6.50e-05	1106	150	18	M39071
Coexpression	GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN	ABCC1 MUC16 WDFY4 UBE2O GUK1 SLC29A1 GNL3	9.16e-05	183	150	7	M8178
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	RANBP2 THEMIS ANK3 TIGD1 HNRNPM ADAM28 IGF1R PHF3 RGPD3 SMCR8 CNOT4	9.41e-05	474	150	11	M40991
Coexpression	ULE_SPLICING_VIA_NOVA2	CHL1 ANK3 SPTAN1 ATP2B1	1.07e-04	43	150	4	M1551
Coexpression	ULE_SPLICING_VIA_NOVA2	CHL1 ANK3 SPTAN1 ATP2B1	1.07e-04	43	150	4	MM666
Coexpression	GSE29618_BCELL_VS_MDC_UP	ADAM28 ADD2 ITPR1 PPP3CC PHF3 CSNK1G3 ATP2A3	1.32e-04	194	150	7	M4943
Coexpression	HU_FETAL_RETINA_BIPOLAR	ANK3 MAP4 WIF1 CRYBG3 ATP2B1	1.45e-04	87	150	5	M39262
Coexpression	GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP	ANK3 GRIA2 ACVR2A F13A1 SLC2A2 WIF1 CABCOCO1	1.49e-04	198	150	7	M6188
Coexpression	HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN	ABCC1 GBF1 VCAN SLC29A1	1.52e-04	47	150	4	M40911
Coexpression	GSE3039_NKT_CELL_VS_B1_BCELL_UP	WDFY4 ADAM28 VCAN PLD1 HSD17B1 ATP2A3 DNAH9	1.54e-04	199	150	7	M6432
Coexpression	GSE3982_EOSINOPHIL_VS_BCELL_UP	MPP1 GRIA2 SLA ITIH4 TLL1 WIF1 PITPNM3	1.54e-04	199	150	7	M5406
Coexpression	GSE27786_CD4_VS_CD8_TCELL_UP	SLC12A6 MAP2 RTN4 CREBBP IGF1R PHF3 ATP2B1	1.59e-04	200	150	7	M4819
Coexpression	GSE19512_NAUTRAL_VS_INDUCED_TREG_DN	SPTAN1 SLA IGF1R COCH VCAN WIF1 SAFB2	1.59e-04	200	150	7	M8359
Coexpression	GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN	MPP1 THEMIS ARMCX4 PAICS SUPT5H TLL1 ECI2	1.59e-04	200	150	7	M4889
Coexpression	GSE17721_CTRL_VS_LPS_2H_BMDC_DN	ZNF131 GRIN2C UBE2O VCAN HELZ2 CRYBG3 VCAM1	1.59e-04	200	150	7	M3688
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP	MPP1 ZMPSTE24 TNFRSF17 PAICS IFNA2 PMPCA AHNAK2	1.59e-04	200	150	7	M8860
Coexpression	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN	ACACA PARK7 HNRNPM PAICS SLC2A2 MESD FUBP3	1.59e-04	200	150	7	M6020
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	RRP1B PHF3 KIF14 ATP2B1 CNOT4 VPS13B	1.92e-04	145	150	6	M1810
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	RANBP2 RRP1B SPTAN1 HNRNPM ITPR1 IGF1R MTAP PHF3 MED23 ATP2B1	2.01e-04	432	150	10	M41149
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	ZNF131 RANBP2 THEMIS ANK3 ITPR1 SEPSECS MED23 ATP2B1 ZNF292	2.54e-04	363	150	9	M41103
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 DNAH3 ANK3 TNC KCTD1 DNAH7 SEC14L3 SPAG17 DNAH9 AHNAK2	1.09e-09	193	149	10	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	CHL1 ANK3 MAP2 SPTAN1 GRIA2 SLA PTPRD AP2B1 ATP2B1	2.47e-08	199	149	9	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	Neuron\|World / Primary Cells by Cluster	CHL1 ANK3 MAP2 SPTAN1 RTN4 GRIA2 SLA PTPRD ASXL3	2.47e-08	199	149	9	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	CHL1 ANK3 MAP2 SPTAN1 RTN4 GRIA2 SLA PTPRD ASXL3	2.47e-08	199	149	9	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	CHL1 ANK3 MAP2 SPTAN1 GRIA2 SLA PTPRD AP2B1 ATP2B1	2.47e-08	199	149	9	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	CHL1 ANK3 MAP2 SPTAN1 RTN4 GRIA2 SLA PTPRD ATP2B1	2.47e-08	199	149	9	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CHL1 ANK3 MAP2 MAP4 SPTAN1 GRIA2 SLA PTPRD EPHA3	2.58e-08	200	149	9	1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital\|World / Primary Cells by Cluster	CHL1 ANK3 SPTAN1 RTN4 SLA PTPRD GUK1 ATP2B1 DYNC1H1	2.58e-08	200	149	9	6bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19\|World / Primary Cells by Cluster	CHL1 ANK3 SPTAN1 RTN4 SLA PTPRD GUK1 ATP2B1 DYNC1H1	2.58e-08	200	149	9	c831d9e0a7178e3634da45548f91fa9e8dc6557c
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	CHL1 DNAH3 MUC16 DNAH7 SPAG17 CABCOCO1 DNAH9 AHNAK2	2.72e-07	191	149	8	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	CHL1 DNAH3 MUC16 DNAH7 SPAG17 CABCOCO1 DNAH9 AHNAK2	2.72e-07	191	149	8	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CHL1 ANK3 MAP2 SPTAN1 GRIA2 SLA PTPRD EPHA3	3.86e-07	200	149	8	84e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CHL1 ANK3 SPTAN1 GRIA2 ACVR2A SLA PTPRD EPHA3	3.86e-07	200	149	8	19055194a5e0ea122f1b8fc62df44813f6843c95
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	DNAH3 PPRC1 TNFRSF10D SAFB2 PITPNM3 SMCR8 DNAH9 SLC29A1	3.86e-07	200	149	8	4db894cfb80fd1f9e01133f345eefd78edd4bc43
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	DNAH3 PPRC1 TNFRSF10D SAFB2 PITPNM3 SMCR8 DNAH9 SLC29A1	3.86e-07	200	149	8	d46a19274c2836ce7494790ce513764dedcadc79
ToppCell	droplet-Kidney-nan-18m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP6V1A AMN ANK3 SLC2A2 ITPR1 PTPRD NUS1	3.27e-06	187	149	7	236e9857729670e87eed30fad58f49e1f56e4a85
ToppCell	B_cells-Memory_B_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	CCDC141 WDFY4 ADAM28 ADD2 ITPR1 COCH ATP2A3	3.89e-06	192	149	7	eef591095921ede098f41a2b81897b18915bb753
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RANBP2 CSNK1G3 CRYBG3 MED23 SMCR8 DYNC1H1 VPS13B	4.02e-06	193	149	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	WDFY4 ADAM28 ITPR1 COCH AP1B1 ATP2A3 ATP2B1	4.16e-06	194	149	7	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37\|World / Primary Cells by Cluster	CHL1 ATP6V1A ANK3 MAP2 RTN4 GRIA2 NRIP3	4.60e-06	197	149	7	00d756bc0231e1b3b88430214338c1059cb11106
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 MUC16 DNAH7 SEC14L3 SPAG17 CABCOCO1 DNAH9	4.60e-06	197	149	7	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 MUC16 DNAH7 SEC14L3 SPAG17 CABCOCO1 DNAH9	4.60e-06	197	149	7	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 MUC16 DNAH7 SEC14L3 SPAG17 CABCOCO1 DNAH9	4.60e-06	197	149	7	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 MUC16 DNAH7 SEC14L3 SPAG17 CABCOCO1 DNAH9	4.60e-06	197	149	7	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH3 SLC1A2 DNAH7 ADAM28 SEC14L3 SPAG17 DNAH9	4.76e-06	198	149	7	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH3 SLC1A2 DNAH7 ADAM28 SEC14L3 SPAG17 DNAH9	4.76e-06	198	149	7	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	HNRNPDL MAP2 RTN4 PTPRD VCAN EPHA3 ZNF292	4.76e-06	198	149	7	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-Neurons\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	ANK3 MAP4 SPTAN1 GRIA2 SLA PTPRD EPHA3	4.92e-06	199	149	7	ae575ed7582f2a4218f6cbcbf5f7f0ce7a5bc26b
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	THSD4 EPYC NDST4 AP2B1 ICAM5 ATP2B1	5.07e-06	130	149	6	c70fb77324916d220d842a575558a8245c276599
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer\|World / Primary Cells by Cluster	CHL1 ANK3 SPTAN1 RTN4 SLA PTPRD ATP2B1	5.08e-06	200	149	7	db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21\|World / Primary Cells by Cluster	CHL1 ANK3 SPTAN1 RTN4 SLA PTPRD ATP2B1	5.08e-06	200	149	7	30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_8\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TNFRSF10D ADAM28 F13A1 PRX CABYR CRYBG3	1.20e-05	151	149	6	a937e3e5a63bfeb37d2cabb3177760ec583dbf11
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	ABCC1 ADD2 CABYR COCH WIF1 ATP2B1	1.91e-05	164	149	6	81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP2 PPRC1 SEMA3G ARMCX4 WIZ EXOC3L4	1.98e-05	165	149	6	62457b7b74c6eae42d91d65e7dc6df6bf8e061f7
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	DNAH3 MUC16 DNAH7 SEC14L3 SPAG17 DNAH9	2.12e-05	167	149	6	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD4 MUC16 GRIN2C PTPRD TLL1 AHNAK2	2.67e-05	174	149	6	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	18-Distal-RBC-RBC\|Distal / Age, Tissue, Lineage and Cell class	MPP1 WDFY4 ADD2 PRDM11 PRG2 PLD1	2.75e-05	175	149	6	7130b816e0c02309c161d8e9ad7cb4bc2469e251
ToppCell	18-Distal-RBC\|Distal / Age, Tissue, Lineage and Cell class	MPP1 WDFY4 ADD2 PRDM11 PRG2 PLD1	2.75e-05	175	149	6	cc476b4244442418b8f21721a82a36209b556b36
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRIP3 MESD PTPRD BRCA2 VCAN VCAM1	2.84e-05	176	149	6	cb8fd56a4f935cdda19d7ab43382cdda7c307667
ToppCell	COVID-19-lung-B_cells\|lung / Disease (COVID-19 only), tissue and cell type	WDFY4 ADAM28 ADD2 ITPR1 ATP2A3 ATP2B1	2.94e-05	177	149	6	f54691e5558091c1734ab15153a10bff15ed171e
ToppCell	droplet-Lung-LUNG-30m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 SLC2A2 PKHD1 SPAG17 CABCOCO1 DNAH9	2.94e-05	177	149	6	7ac99ff16df94b4e08d361e3d98a7b3af8d6ee3b
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST4 GRIA2 ITPR1 PTPRD BEND7 GNL3	2.94e-05	177	149	6	1dc69c661e70e7e22bd9d7cf953eb638da9fd43c
ToppCell	droplet-Lung-LUNG-30m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 SLC2A2 PKHD1 SPAG17 CABCOCO1 DNAH9	2.94e-05	177	149	6	092a345cb802f183322aa5542341ba2d96d4f06a
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST4 GRIA2 ITPR1 PTPRD BEND7 GNL3	2.94e-05	177	149	6	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ACACA ANK3 CACNA2D2 CCDC141 PTPRD WIF1	3.22e-05	180	149	6	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	GBF1 TNC TNFRSF17 COCH RECQL5 KIF14	3.33e-05	181	149	6	c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db
ToppCell	severe_influenza-B_memory\|severe_influenza / disease group, cell group and cell class (v2)	MUC16 TNFRSF17 CCDC141 ADAM28 ADD2 COCH	3.33e-05	181	149	6	92e572c92109a6dae0f73138c57c3bbd2e0a2f36
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ATP6V1A NDST4 GRIN2D NRIP3 ST8SIA5 CEP170B	3.43e-05	182	149	6	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CHL1 EPYC GRIA2 TRAPPC8 FUBP3 SLC29A1	3.43e-05	182	149	6	00a148b1e499bf16325491536d187d4dd6b70c06
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ERCC5 ZFC3H1 WIZ WIF1 CRYBG3 ZNF454	3.65e-05	184	149	6	a6dee97ee4ef9d89e11d17339e0dadaea1210ce5
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 PTPRD ASXL3 PKHD1 SPAG17 DNAH9	3.65e-05	184	149	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 PTPRD ASXL3 PKHD1 SPAG17 DNAH9	3.65e-05	184	149	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 PTPRD ASXL3 PKHD1 SPAG17 DNAH9	3.65e-05	184	149	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAP2 WDFY4 ADAM28 ZNF711 COCH ATP2B1	3.76e-05	185	149	6	05e6eb78ead81268c1656e7ffe34f9cb7329b908
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THEMIS TNC ASIC5 F13A1 TLL1 EPHA3	3.76e-05	185	149	6	a1b2525da018abe458908cab7268bd403ee98d92
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 MUC16 DNAH7 SPAG17 CABCOCO1 DNAH9	3.76e-05	185	149	6	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DSN1 F13A1 PRX UBE2O PPP2R5D PMPCA	3.76e-05	185	149	6	daea170d827226dda6750bf1838ffd82f070c4d4
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RTN4 PRRT2 SLC1A2 ITPR1 ICAM5 ATP2B1	3.87e-05	186	149	6	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	background-B_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	TNFRSF17 CCDC141 WDFY4 ADAM28 ITPR1 ATP2A3	4.11e-05	188	149	6	9acb7a95e3095f15918a5d094107d1d565a42842
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 ANK3 CCDC141 ITIH4 BEND7 CEP170B	4.36e-05	190	149	6	aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 TNC ACVR2A PTPRD VCAN VCAM1	4.36e-05	190	149	6	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 ANK3 CCDC141 ITIH4 BEND7 CEP170B	4.36e-05	190	149	6	a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C6orf62 MAP4 TNC SPTAN1 RTN4 ATP2B1	4.36e-05	190	149	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 TNC NRIP3 PTPRD VCAN VCAM1	4.49e-05	191	149	6	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 CACNA2D2 SLC1A2 PTPRD WIF1 PKHD1	4.49e-05	191	149	6	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA ANK3 CACNA2D2 CCDC141 PTPRD WIF1	4.49e-05	191	149	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 ANK3 CCDC141 ITIH4 SEC14L3 BEND7	4.49e-05	191	149	6	c06bbad24e4897b2c3b5015e4de02411ebf75367
ToppCell	facs-Lung-nan-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 ANK3 CCDC141 ITIH4 SEC14L3 BEND7	4.49e-05	191	149	6	5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e
ToppCell	background-Cholangiocytes\|World / Sample and Cell Type and Tumor Cluster (all cells)	THSD4 ANK3 MAP2 CCDC141 PTPRD PKHD1	4.49e-05	191	149	6	99aa8d685767a72bef9f05e7cc8913126a048c39
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 MUC16 DNAH7 SPAG17 CABCOCO1 DNAH9	4.49e-05	191	149	6	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 MUC16 DNAH7 SPAG17 CABCOCO1 DNAH9	4.49e-05	191	149	6	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 MUC16 DNAH7 SPAG17 CABCOCO1 DNAH9	4.49e-05	191	149	6	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	ANK3 MAP2 GRIA2 DYNC1H1	4.56e-05	59	149	4	74590437b1d9a2a8fe56d79b2e66803528b81298
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 TNC ACVR2A NRIP3 PTPRD VCAM1	4.62e-05	192	149	6	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 TNC ACVR2A NRIP3 PTPRD VCAM1	4.62e-05	192	149	6	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 CACNA2D2 CCDC141 PTPRD WIF1 PKHD1	4.62e-05	192	149	6	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH3 MUC16 DNAH7 SPAG17 CABCOCO1 DNAH9	4.62e-05	192	149	6	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	WDFY4 ADAM28 ITPR1 ZNF711 PMPCA ATP2B1	4.76e-05	193	149	6	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA ANK3 CACNA2D2 CCDC141 PTPRD WIF1	4.76e-05	193	149	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBF1 SLC2A2 AP1B1 GUK1 ATP2A3 CEP170B	4.76e-05	193	149	6	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA ANK3 CACNA2D2 CCDC141 PTPRD WIF1	4.76e-05	193	149	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS CCDC141 SLA WDFY4 ADAM28 F13A1	4.90e-05	194	149	6	96f16bcd393a0d3f8df479b172b5360ae5a1e663
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS CCDC141 SLA WDFY4 ADAM28 F13A1	4.90e-05	194	149	6	0866ab6792cee274a71991d5c37a37f574ff446e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA ANK3 CACNA2D2 CCDC141 PTPRD WIF1	4.90e-05	194	149	6	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MPP1 CCDC141 SLA PLEKHG5 F13A1 AP1B1	4.90e-05	194	149	6	45708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	DNAH3 ANK3 DNAH7 SPAG17 CABCOCO1 DNAH9	5.04e-05	195	149	6	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBF1 SLC2A2 IGF1R AP1B1 ST8SIA5 ATP2A3	5.04e-05	195	149	6	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MPP1 CCDC141 SLA WDFY4 PLEKHG5 F13A1	5.04e-05	195	149	6	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS CCDC141 SLA WDFY4 ADAM28 F13A1	5.04e-05	195	149	6	ce8215d503cad3a9bc7d5d2be4adb57408015593
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ACACA ANK3 IGF1R PTPRD VPS13B	5.18e-05	196	149	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 ADAM28 VCAN CRYBG3 VCAM1 EPHA3	5.18e-05	196	149	6	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	THSD4 TNC PRRT2 PTPRD ASXL3 EPHA3	5.18e-05	196	149	6	57df2a57b35be9851ac0b1e5731baa53052511f0
ToppCell	cellseq-Epithelial-Epithelial_Airway\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHL1 TNC MUC16 KCTD1 ADAM28 AHNAK2	5.18e-05	196	149	6	faa39c567f24403e511b240c1d1a654ffadd8473
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	DNAH3 ANK3 DNAH7 SPAG17 CABCOCO1 DNAH9	5.18e-05	196	149	6	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-PFC\|World / Primary Cells by Cluster	RTN4 SLA ZNF711 GUK1 VCAN DYNC1H1	5.33e-05	197	149	6	2c3b0072f8e1e09c77a85c6fc3133d1796932fb2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area\|World / Primary Cells by Cluster	CHL1 ANK3 MAP2 GRIA2 VCAN ATP2B1	5.33e-05	197	149	6	79b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer\|World / Primary Cells by Cluster	ATP6V1A ANK3 MAP2 RTN4 NDST4 GRIA2	5.33e-05	197	149	6	41e823b14697827f657b13adb3afa581bd91a9cb
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33\|World / Primary Cells by Cluster	CHL1 ANK3 MAP2 GRIA2 VCAN ATP2B1	5.33e-05	197	149	6	d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCell	B_cells-Memory_B_cells\|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ANK3 CCDC141 ADAM28 ADD2 ITPR1 COCH	5.33e-05	197	149	6	cdd1dbdaf257b0864c6dc8c1cbed6e9b68e114b7
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-PFC-29\|World / Primary Cells by Cluster	RTN4 SLA ZNF711 GUK1 VCAN DYNC1H1	5.33e-05	197	149	6	c5bc0e7eb85642b270efc2ba92b13a736af22052
Drug	3,5-dihydroxyphenylglycine	MAP4 GRIA2 GRIN2C GRIN2D ITPR1 PLD1 ATP2A3	1.41e-07	60	151	7	CID000108001
Drug	magnesium	ATP6V1A ABCC1 DNAH3 RANBP2 TNC RTN4 GRIA2 GRIN2C GRIN2D TNFRSF17 SLA PAICS TKFC POLR3B PPP3CC AP2B1 ICAM5 CSNK1G3 VCAN PLD1 ATP2A3 ATP2B1 DNAH9 DYNC1H1 GNL3 SDHA EPHA3	1.68e-07	1325	151	27	CID000000888
Drug	L-CCG-I	ACACA MAP4 GRIA2 GRIN2C GRIN2D SLC1A2	9.62e-07	50	151	6	CID000001271
Drug	alpha-methyl-4-carboxyphenylglycine	MAP4 GRIA2 GRIN2C GRIN2D ITPR1	2.09e-06	32	151	5	CID000001222
Drug	1-aminoindan-1,5-dicarboxylic acid	MAP4 GRIA2 GRIN2C GRIN2D PLD1	2.45e-06	33	151	5	CID000002071
Drug	pyrrolidine-2,4-dicarboxylate	MAP4 GRIA2 GRIN2C GRIN2D SLC1A2 MED23	3.17e-06	61	151	6	CID000003868
Drug	N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid	GRIA2 GRIN2D SLC1A2 CREBBP PPP3CC	3.32e-06	35	151	5	ctd:C520612
Drug	4CPG	MAP4 GRIA2 GRIN2C GRIN2D SLC1A2	5.05e-06	38	151	5	CID000005115
Drug	MAPS	MAP2 MAP4 PARK7 SPTAN1 ITIH4 PRG2 KIF14 DNAH9 DYNC1H1	5.40e-06	191	151	9	CID000066161
Drug	orthovanadate	ATP6V1A ABCC1 DNAH3 PPRC1 TNC SLC2A2 PTPRD PLD1 GMPPB ATP2A3 ATP2B1 DNAH9 DYNC1H1	6.96e-06	435	151	13	CID000061672
Drug	AC1NNRU4	MAP4 TNC GRIA2 GRIN2C GRIN2D	7.42e-06	41	151	5	CID005126051
Drug	N-methyl-DL-aspartic acid	MAP2 CACNA2D2 MAP4 GRIA2 GRIN2C ASIC5 GRIN2D SLC1A2 ITIH4 ITPR1 PPP3CC GUK1 ICAM5 PLD1 GNL3 EPHA3	7.70e-06	655	151	16	CID000004376
Drug	Methylmercury Compounds	ATP6V1A ABCC1 ACACA MAP2 TNC PARK7 SLC1A2 DNAH7 PAICS SLC2A2 COCH AP1B1 PMPCA AP2B1 SUPT5H RABGEF1 GMPPB SDHA	1.44e-05	851	151	18	ctd:D008767
Drug	piperazine-2,3-dicarboxylic acid	GRIA2 GRIN2C GRIN2D	1.56e-05	8	151	3	CID000280973
Drug	fluo-3	ABCC1 GRIN2C GRIN2D ITPR1 PTPRD ATP2A3 ATP2B1	1.74e-05	122	151	7	CID000104978
Drug	riluzole	MAP2 CACNA2D2 GRIA2 GRIN2C ASIC5 GRIN2D SLC1A2 ITPR1	2.17e-05	174	151	8	CID000005070
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	ANK3 MAP4 TNC MEX3D BRCA2 AP2B1 RECQL5 KIF14	3.12e-05	183	151	8	7088_DN
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	C6orf62 ANK3 MAP4 PAICS ZNF711 MTAP PHF3 CNOT4	3.64e-05	187	151	8	4323_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	ABCC1 ACACA MAP4 SEMA3G ADAM28 MTAP VCAN SLC29A1	3.78e-05	188	151	8	6186_DN
Drug	vanadyl	DNAH3 SLC2A2 IGF1R PPP3CC PLD1 ATP2A3 ATP2B1 DNAH9 DYNC1H1 VCAM1	4.03e-05	307	151	10	CID000061671
Drug	GYKI 52466	GRIA2 GRIN2C GRIN2D SLC1A2 MED23	4.14e-05	58	151	5	CID000003538
Drug	CHEMBL83995	DNAH9 DYNC1H1	4.37e-05	2	151	2	CID009571169
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	ANK3 COCH MTAP WIZ SUPT5H CNOT4 ZNF222 ZNF292	4.39e-05	192	151	8	7280_DN
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A	GBF1 RRP1B PPRC1 TKFC SUPT5H PHF3 SAFB2 SLC29A1	5.08e-05	196	151	8	1819_DN
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; HL60; HT_HG-U133A	GBF1 TKFC MTAP PPP3CC BRCA2 PHF3 PLD1 ATP2A3	5.08e-05	196	151	8	2351_DN
Drug	Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	EPYC TNC GRIN2C PRDM11 AP2B1 VCAN VCAM1 AHNAK2	5.08e-05	196	151	8	6084_UP
Drug	4-methylglutamic acid	GRIA2 GRIN2C GRIN2D SLC1A2	5.09e-05	31	151	4	CID000005365
Drug	LY235959	GRIA2 GRIN2C GRIN2D SLC1A2	5.09e-05	31	151	4	CID000131938
Drug	Trolox [53188-07-1]; Down 200; 16uM; HL60; HG-U133A	ABCC1 GBF1 ZMPSTE24 MAP4 PPP2R5D AP2B1 PLD1 SLC29A1	5.26e-05	197	151	8	1734_DN
Drug	Mesalamine [89-57-6]; Down 200; 26.2uM; MCF7; HT_HG-U133A	MAP4 EPYC SPTAN1 PAICS PRX WIZ RECQL5 CNOT4	5.26e-05	197	151	8	3584_DN
Drug	nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A	DNAH3 ITPR1 PHF3 VCAN NUS1 RECQL5 PLD1 ZNF222	5.26e-05	197	151	8	1223_UP
Drug	Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A	ANK3 MAP4 SPTAN1 CREBBP PAICS F13A1 WIZ RECQL5	5.46e-05	198	151	8	2492_UP
Drug	Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; HL60; HT_HG-U133A	ANK3 MAP4 EPYC MTAP WIZ WIF1 NR0B1 SAFB2	5.46e-05	198	151	8	2550_UP
Drug	DCG-IV	MAP4 GRIA2 GRIN2C GRIN2D SLC1A2	8.94e-05	68	151	5	CID000115114
Drug	gacyclidine	RTN4 GRIA2 GRIN2C GRIN2D	9.28e-05	36	151	4	CID000176265
Drug	1-aminocyclopentane-1,3-dicarboxylate	MAP4 GRIN2C GRIN2D ITPR1 PLD1 GNL3	9.84e-05	111	151	6	CID000001310
Drug	Haloperidol	CHL1 ABCC1 MAP2 PARK7 RTN4 GRIA2 GRIN2C GRIN2D SLC1A2 AP2B1	9.89e-05	342	151	10	ctd:D006220
Drug	benzyloxyaspartate	MAP2 GRIN2C GRIN2D SLC1A2	1.04e-04	37	151	4	CID004133412
Drug	isoflurane	GRIA2 GRIN2C ASIC5 GRIN2D TNFRSF17 CREBBP IFNA2 ATP2A3 ATP2B1	1.06e-04	279	151	9	CID000003763
Disease	Colorectal Carcinoma	CHL1 ABCC1 DNAH3 ACACA MAP2 RTN4 IFNA2 CABYR PTPRD ICAM5 PRG2 WIF1 PKHD1 SPAG17 SLC29A1 EPHA3 ZNF292	7.16e-08	702	145	17	C0009402
Disease	Intellectual Disability	CHL1 GRIA2 GRIN2D PRRT2 SLC1A2 POLR3B PPP2R5D AP1B1 MED23 DYNC1H1 ZNF292	1.40e-05	447	145	11	C3714756
Disease	epilepsy (implicated_via_orthology)	CHL1 SLC12A6 CACNA2D2 GRIN2C GRIN2D NUS1 DYNC1H1	1.68e-05	163	145	7	DOID:1826 (implicated_via_orthology)
Disease	schizophrenia (is_marker_for)	ANK3 MAP2 GRIN2D PPP3CC	6.52e-05	44	145	4	DOID:5419 (is_marker_for)
Disease	gastrinoma (is_marker_for)	SLC2A2 IGF1R	7.17e-05	3	145	2	DOID:5577 (is_marker_for)
Disease	Malignant neoplasm of breast	ABCC1 SPTAN1 NBN GRIN2D TRAPPC8 IFNA2 SLC2A2 IGF1R PTPRD BRCA2 ICAM5 TLL1 BEND7 ATP2A3 DNAH9 VPS13B	8.09e-05	1074	145	16	C0006142
Disease	antibody measurement	THSD4 F13A1 PTPRD ASXL3	9.98e-05	49	145	4	EFO_0004556
Disease	cortical surface area measurement	THSD4 ANK3 MAP2 ACVR2A SLA DNAH7 SEPSECS COCH PMPCA TLL1 VCAN PKHD1 HSD17B1 MED23 SPAG17 CABCOCO1 CNOT4 EPHA3	1.11e-04	1345	145	18	EFO_0010736
Disease	Stomatitis	NBN IFNA2	1.43e-04	4	145	2	C0038362
Disease	Oral Mucositis	NBN IFNA2	1.43e-04	4	145	2	C1568868
Disease	temperament and character inventory	SLA SEPSECS PTPRD	2.18e-04	24	145	3	EFO_0004825
Disease	Progeria	ZMPSTE24 ANK3	2.38e-04	5	145	2	C0033300
Disease	corpus callosum mid-anterior volume measurement	SLA SLC1A2 SEPSECS	3.12e-04	27	145	3	EFO_0010297
Disease	sugar consumption measurement	MAP4 ASXL3 PKHD1 KIF14 VPS13B	3.24e-04	120	145	5	EFO_0010158
Disease	Colorectal Neoplasms	ABCC1 IFNA2 CABYR PTPRD ICAM5 WIF1 ZNF292	4.57e-04	277	145	7	C0009404
Disease	obsessive-compulsive symptom measurement	LRRC8D PTPRD SAFB2	4.72e-04	31	145	3	EFO_0007802
Disease	Lymphoma, Non-Hodgkin	NBN CREBBP IFNA2	5.19e-04	32	145	3	C0024305
Disease	macrophage inflammatory protein 1b measurement	ACACA ANK3 CACNA2D2 MAP4 AP2B1	5.74e-04	136	145	5	EFO_0008219
Disease	schizophrenia (is_implicated_in)	CHL1 ANK3 PAICS PPP3CC	6.02e-04	78	145	4	DOID:5419 (is_implicated_in)
Disease	Bipolar Disorder	SLC12A6 ANK3 MAP2 GRIA2 SLC1A2 ITIH4 ITPR1 PPP3CC BRCA2	6.10e-04	477	145	9	C0005586
Disease	Developmental delay (disorder)	CACNA2D2 TKFC IGF1R	7.99e-04	37	145	3	C0424605
Disease	alcohol dependence (implicated_via_orthology)	IGF1R SLC29A1	8.44e-04	9	145	2	DOID:0050741 (implicated_via_orthology)
Disease	WNT1-inducible-signaling pathway protein 1 measurement	SLA SEPSECS	1.05e-03	10	145	2	EFO_0008321
Disease	Neurodevelopmental Disorders	ITPR1 PPP2R5D ASXL3 ZNF292	1.16e-03	93	145	4	C1535926
Disease	melanoma	ERCC5 TNC IFNA2 MTAP BRCA2 NUS1	1.46e-03	248	145	6	C0025202
Disease	Charcot-Marie-Tooth disease (is_implicated_in)	SLC12A6 POLR3B	1.53e-03	12	145	2	DOID:10595 (is_implicated_in)
Disease	pancreatic cancer (is_marker_for)	MUC16 ACVR2A MTAP VCAM1	1.58e-03	101	145	4	DOID:1793 (is_marker_for)
Disease	Hypoxanthine measurement	ERCC5 PKHD1	1.81e-03	13	145	2	EFO_0021604
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	ITIH4 IGF1R	1.81e-03	13	145	2	DOID:332 (biomarker_via_orthology)
Disease	Fetal Alcohol Spectrum Disorders	CHL1 ANK3	1.81e-03	13	145	2	C2985290
Disease	Epilepsy	CACNA2D2 PRRT2 SLC1A2 ASXL3	2.09e-03	109	145	4	C0014544
Disease	response to methotrexate, aspartate aminotransferase measurement	THSD4 MAP2	2.10e-03	14	145	2	EFO_0004736, GO_0031427
Disease	nephroblastoma (is_implicated_in)	IGF1R BRCA2	2.10e-03	14	145	2	DOID:2154 (is_implicated_in)
Disease	Hereditary Breast and Ovarian Cancer Syndrome	NBN BRCA2	2.10e-03	14	145	2	C0677776
Disease	pathological myopia	OR5M3 PTPRD AP1B1 DNAH9	2.23e-03	111	145	4	EFO_0004207
Disease	Huntington's disease (is_marker_for)	MAP2 SLC1A2 CREBBP	2.27e-03	53	145	3	DOID:12858 (is_marker_for)
Disease	Peripheral Nervous System Diseases	SLC12A6 ABCC1 IGF1R	2.40e-03	54	145	3	C4721453
Disease	Lymphoma, Follicular, Grade 2	CREBBP IFNA2	2.41e-03	15	145	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	CREBBP IFNA2	2.41e-03	15	145	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	CREBBP IFNA2	2.41e-03	15	145	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	CREBBP IFNA2	2.41e-03	15	145	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	CREBBP IFNA2	2.41e-03	15	145	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	CREBBP IFNA2	2.41e-03	15	145	2	C0079758
Disease	third ventricle volume measurement	ANK3 PTPRD	2.41e-03	15	145	2	EFO_0010335
Disease	ovarian cancer (is_implicated_in)	MUC16 NBN BRCA2	2.66e-03	56	145	3	DOID:2394 (is_implicated_in)
Disease	partial epilepsy	TBC1D32 PTPRD	3.11e-03	17	145	2	EFO_0004263
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	ATP2B1 ZNF292	3.11e-03	17	145	2	DOID:0060307 (is_implicated_in)
Disease	Fetal Alcohol Syndrome	CHL1 ANK3	3.11e-03	17	145	2	C0015923
Disease	sphingosine 1-phosphate measurement	ITPR1 UBE2O	3.48e-03	18	145	2	EFO_0800185
Disease	Idiopathic hypogonadotropic hypogonadism	CCDC141 POLR3B	3.48e-03	18	145	2	C0342384
Disease	left ventricular mass	CCDC141 IGF1R	3.48e-03	18	145	2	EFO_0009289
Disease	Prostatic Neoplasms	NDST4 NBN CREBBP ADAM28 ITPR1 MTAP BRCA2 HSD17B1 ZNF292	3.50e-03	616	145	9	C0033578
Disease	Malignant neoplasm of prostate	NDST4 NBN CREBBP ADAM28 ITPR1 MTAP BRCA2 HSD17B1 ZNF292	3.50e-03	616	145	9	C0376358
Disease	Lewy body dementia (is_marker_for)	MAP2 IGF1R	3.88e-03	19	145	2	DOID:12217 (is_marker_for)
Disease	Global developmental delay	CACNA2D2 TKFC IGF1R AP1B1	4.27e-03	133	145	4	C0557874
Disease	Lymphoma, Follicular	CREBBP IFNA2	4.30e-03	20	145	2	C0024301
Disease	Microcephaly	KIF14 DYNC1H1 ZNF292	4.42e-03	67	145	3	C0025958

Protein segments in the cluster

Peptide	Gene	Start	Entry
FEEIKVPSAMAVLIT	EXOC3L4	706	Q17RC7
KSALFEVSEVIPVMT	C6orf62	46	Q9GZU0
DMDPLVGFTIEDVKS	CABCOCO1	156	Q8IVU9
MTVGKDVSSLFPDVV	AP2B1	41	P63010
EITKSPFMGKTEEEV	VCAN	706	P13611
ASSPKDMVIIVDVSG	CACNA2D2	286	Q9NY47
AEGDIVKTEMTPVTV	CRYBG3	1651	Q68DQ2
DISIFSGSEMLPVVK	TBC1D32	596	Q96NH3
KTFDPEDTSQEIGMV	ADAM28	586	Q9UKQ2
TVVTMVTNVDFPPKE	ACVR2A	496	P27037
VVKSESGEEMLVPFQ	ARMC1	211	Q9NVT9
VVASSDKTVEVKPGM	CREBBP	1361	Q92793
NFVPTVIMDPSKIEE	ACACA	1476	Q13085
EILDVIEPSEFSKVM	PPP2R5D	386	Q14738
VDVATSMPVVIKEVP	CABYR	196	O75952
GAVEFPADKMVSVLV	AMN	46	Q9BXJ7
MTVGKDVSALFPDVV	AP1B1	41	Q10567
VTETKPTGAEVREME	ANKRD24	596	Q8TF21
EATPGEMVSAETKVA	CEP170B	301	Q9Y4F5
MVGAEPETQSESKVV	ARMCX4	106	Q5H9R4
GEETTTAFVEPLVIM	ATP2A3	81	Q93084
DIVKTVIEPMASEGL	ATP2B1	631	P20020
GKSESPQEEMTVVID	ASXL3	521	Q9C0F0
EGLTTMPKNVVFVID	ITIH4	266	Q14624
VVQMPEKVELVTGEE	RANBP2	2016	P49792
MTTVPEVVLAKEAGI	MTAP	196	Q13126
IPEVSDMVVKAITDI	RABGEF1	261	Q9UJ41
FGEIENIELPMDTKT	HNRNPDL	256	O14979
SVGAITEATKMEVPS	MUC16	4626	Q8WXI7
VFMSGKEITVEHPDT	KIF14	381	Q15058
ETEATPVPIKDMEIA	MAP4	581	P27816
GIAMSEEIEFIVPSV	CHL1	116	O00533
MFPETLTISEKFTVV	MGAT2	406	Q10469
VTTIFPISKMAKGEE	ITPR1	901	Q14643
DTKMPTTERETEFAV	IMPG1	216	Q17R60
MFVTVSGSPTEKETE	MESD	116	Q14696
VAATEIKMEEESGAP	HNRNPM	11	P52272
TSIEKEVFPIMAKEG	GMPPB	191	Q9Y5P6
EIISSIKEEMEPGFR	IGF1R	1261	P08069
VDKVEIEIATVMPSG	EPYC	51	Q99645
EVDKMVVTLTELPSG	GRIA2	391	P42262
KTVVVSAESPPEMDE	ICAM5	656	Q9UMF0
AKGAEEMETVIPVDV	PARK7	11	Q99497
KSLIEEVFPEIGDVM	KCTD1	161	Q719H9
MGLVITEVEQEPSFS	NUS1	101	Q96E22
TVITEEFKVPDKMVG	FUBP3	76	Q96I24
MTEDKVTGTLVFTVI	SLC2A2	1	P11168
EVVKTEVIEEAFPGM	MED23	11	Q9ULK4
EPVFIVTGRKEDVEM	MEX3D	221	Q86XN8
DMTVTVEFTNPLKET	F13A1	646	P00488
FTVKPADVEVTMTSE	LRRC37B	341	Q96QE4
ATVMDEVQKFLGVTP	NDST4	776	Q9H3R1
PTEESVEQGKMVAVF	OR5M3	261	Q8NGP4
PITAPTEVEVMDETK	CSNK1G3	416	Q9Y6M4
FETVEVSEPSMLQKI	NR0B1	306	P51843
DGAVESISVPDMVDK	PRG2	71	P13727
SEISEMKGVEESPKV	PRRT2	6	Q7Z6L0
VVQMPEKVELVTGEE	RGPD3	1041	A6NKT7
MESSKEPGLFDVVII	GUK1	156	Q16774
MEGSPVTLEVEVTGF	CCDC141	1421	Q6ZP82
KMEIGKTETFSDVPV	BRCA2	2191	P51587
EIVGMISSEKETVPF	DNAH3	1216	Q8TD57
TAFMEKVLGSPEEVL	HSD17B1	191	P14061
NETVTEVPEETKMVI	SLC1A2	216	P43004
DVMIKAVSFVPRVET	DNAH7	431	Q8WXX0
MTSVTRSEIIDEKGP	DSN1	1	Q9H410
EGPGEITDKIEAVMT	ANK3	3736	Q12955
PTTTSIEVQYVEKME	ASIC5	91	Q9NY37
EGVVTKSKPVMIVTE	EPHA3	686	P29320
VGVTETPLMKEDSIL	IFNA2	126	P01563
ISSREGEEVMFKTPV	DYNC1H1	1676	Q14204
GEEVMFKTPVSITEH	DYNC1H1	1681	Q14204
FVGTDPASDEVVLMK	GBF1	121	Q92538
ASIEVVKPMEAASAI	GNL3	326	Q9BVP2
KETQPIFLGDESMEI	BEND7	41	Q8N7W2
KVGDTVRVPVSFEAM	IGFN1	961	Q86VF2
TLVVTSEDGITKIMF	ECI2	141	O75521
LIQFEKVTEEPMGIT	MPP1	71	Q00013
EGIEPTVKQSISKFM	DNAH9	3001	Q9NYC9
VVTAMVKAEPGDEAL	HELZ2	991	Q9BYK8
EEIEVMAKSIDFPLT	ZMPSTE24	236	O75844
PEELGMVQDVTFVDK	COCH	306	O43405
ASVRFMVTPTKIDDI	SLC12A6	11	Q9UHW9
KVSFTVEVLLPDEGM	SEC14L3	376	Q9UDX4
VIDTPVFELKETLMG	HARS1	91	P12081
MPTLESETEAAVPKV	PPRC1	391	Q5VV67
FSAEKPVIEVPSMTI	LRRC8D	261	Q7L1W4
VGFGEEMVKEISIPE	PTPRD	901	P23468
EELEFKMNEITTPGT	PCDHGA1	136	Q9Y5H4
FSKELDTVDSMIPEV	ABCC1	1076	P33527
IMGKTDKEEIPFVET	NRIP3	216	Q9NQ35
PDTKVGSFMIRESET	SLA	101	Q13239
TKVTEEVVANMPEGL	RTN4	536	Q9NQC3
PSAIFSTTVKVMGEE	RXFP3	231	Q9NSD7
EIITKEFILMGGTVD	PMPCA	406	Q10713
LEMTFIPTIEDTGKA	VCAM1	466	P19320
FVPEETMEEQKTKVG	RRP1B	226	Q14684
VTPGEKIVLNFTTMD	TLL1	381	O43897
TAMIFAGVDVTKEPI	SDHA	386	P31040
PEAEIGLAVIFMTTK	NBN	306	O60934
VQDTETVPSVMDGKE	PLD1	931	Q13393
GDMVTVVKTEVCSPL	PRDM11	51	Q9NQV5
TIPQGMEVVKDTSGE	PRDM11	146	Q9NQV5
VGTEAFPISDESMIK	ERCC5	481	P28715
TMDVGVKTDVVTVNP	ST8SIA5	201	O15466
AVTKVTEFILMGITD	OR8K1	11	Q8NGG5
FVPVEDTPKTLDMAV	WIZ	171	O95785
GAKPMEEIVTVETVQ	PKHD1	2086	P08F94
FAMSAVITEGVKPTL	SUPT5H	376	O00267
PTEESVEQGKMVAVF	OR5M9	261	Q8NGP3
TITIGMFPAVTVEVK	SLC29A1	301	Q99808
MFPAVTVEVKSSIAG	SLC29A1	306	Q99808
IEVEKTMFEKGPTFI	SPAG17	1046	Q6Q759
MISAPDVVAFTKEEE	SMCR8	1	Q8TEV9
SIEVSVDVSAPKMEA	AHNAK2	4481	Q8IVF2
DEVEKSSSGMPIRIE	ADD2	466	P35612
VAGEEEVKVSTMPLS	CNOT4	541	O95628
KTPAAEETVTTILGM	TNFRSF10D	191	Q9UBN6
MEEKVPVIVATISFG	RECQL5	306	O94762
TLVDMKIEFGVDVTT	PAICS	186	P22234
EKTMIEVDAPITVCG	PPP3CC	71	P48454
TETLAMVVVEPGDTL	PLEKHG5	756	O94827
MTSKEFPIVTEVIEA	THEMIS	276	Q8N1K5
VPTLKSMVTFEDVAV	ZNF132	31	P52740
TPGEDAVNIVEMTTK	TIGD1	476	Q96MW7
MDPSGVKVLETAEDI	SPTAN1	1	Q13813
VSEMKLPEVSEVAVP	PRX	551	Q9BXM0
LVSIIAMKGFEESEP	TNC	1776	P24821
ATSLPEGIMVKTFED	UBE2O	966	Q9C0C9
PEEIESMTASVDVGK	ZNF292	2201	O60281
VVSTEEKEFQPLDVM	WDFY4	1121	Q6ZS81
SGKTGETVVEEMIAT	PHF3	301	Q92576
FPELTMEVDGKVESI	ATP6V1A	291	P38606
FEEDILIVSEGKMAP	WIF1	51	Q9Y5W5
SEDIPIVIIFKAMGV	POLR3B	231	Q9NW08
TVVMDKSKGEPVISV	SAFB2	571	Q14151
TGEKVDILVMAEPSS	PITPNM3	666	Q9BZ71
LDVMKNEIVTETSPF	MAP2	326	P11137
IFIPKTEEMQPTVEA	VPS13B	1556	Q7Z7G8
EDTVVLKIGSVAMAP	VPS13B	1576	Q7Z7G8
LPTMVQESVTFKDVA	ZNF454	6	Q8N9F8
EEVKQLVTSEPEMIG	TRAPPC8	791	Q9Y2L5
LVTSEPEMIGAEVIS	TRAPPC8	796	Q9Y2L5
QVFKVPTPITEMEIS	SEMA3G	486	Q9NS98
FKSMITAGFEPVVIE	SEPSECS	176	Q9HD40
FTQEPLVEIEGVSKM	ZNF131	66	P52739
VEIPEGATKINITEM	THSD4	431	Q6ZMP0
PVEMVVIGDDSAFTV	TKFC	131	Q3LXA3
GVDSPTMVSEEVLVT	ZNF711	151	Q9Y462
LPAMEEGATILVTTK	TNFRSF17	146	Q02223
VDFVTAQSKTMEVKP	ZFC3H1	1126	O60293
QEEDFLLPETTVMKG	ZSCAN5C	196	A6NGD5
SVGGKIQTEMETVPE	ZNF222	46	Q9UK12
LTPEEDGVKVDVIMV	TMPRSS11A	106	Q6ZMR5
DFSVPFVETGISVMV	GRIN2C	521	Q14957
DFSVPFVETGISVMV	GRIN2D	551	O15399